Ischemia-modified albumin and flap viability

European Surgical Research

Volumn 42, Issue 2, 2009, Pages 87-90

  Livaoglu M ^a,b   Kerimoglu S ^a   Karahan, S C ^a   Mentese A ^a   Sozen E ^a   Karacal N ^a   Topbas M ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Flap viability; Ischemia modified albumin

Indexed keywords

BIOLOGICAL MARKER; ISCHEMIA MODIFIED ALBUMIN;

ALBUMIN BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; GRAFT NECROSIS; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RAT; SKIN FLAP; SKIN FLAP SURVIVAL; SKIN TRANSPLANTATION; WISTAR RAT;

ANIMALS; EARLY DIAGNOSIS; ISCHEMIA; MALE; NECROSIS; RATS; RATS, WISTAR; SERUM ALBUMIN; SURGICAL FLAPS; TISSUE SURVIVAL;

EID: 57049121145     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000180115     Document Type: Article

References (18)

1. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW: Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985-991.
2. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC: Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-2405.
3. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC: Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004;50:1656-1660.
4. Bar-Or D, Lau E, Winkler JV: A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2000;19:311-315.
5. Aparci M, Kardesoglu E, Ozmen N, Ozcan O, Cebeci BS, Cingozbay BY, Dincturk M: Prognostic significance of ischemia-modified albumin in patients with acute coronary syndrome. Coron Artery Dis 2007;18:367-373.
6. Kamolz LP, Giovanoli P, Haslik W, Koller R, Frey M: Continuous free-flap monitoring with tissue-oxygen measurements: three-year experience. J Reconstr Microsurg 2002;18:487-491.
7. Hölzle F, Loeffelbein DJ, Nolte D, Wolff KD: Free flap monitoring using simultaneous non-invasive laser Doppler flowmetry and tissue spectrophotometry. J Craniomaxillofac Surg 2006;34:25-33.
8. Heller L, Levin LS, Klitzman B: Laser Doppler flowmeter monitoring of free-tissue transfers: blood flow in normal and complicated cases. Plast Reconstr Surg 2001;107:1739-1745.
9. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS; Committee on Standardization of Markers of Cardiac Damage of the IFCC: Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-824.
10. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Binter P, et al: Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-470.
11. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E: Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001;268:42-47.
12. Jallali N, Ridha H, Butler PE: Postoperative monitoring of free flaps in UK plastic surgery units. Microsurgery 2005;25:469-472.
13. Top H, Sarikaya A, Aygit AC, Benlier E, Kiyak M: Review of monitoring free muscle flap transfers in reconstructive surgery: role of 99mTc sestamibi scintigraphy. Nucl Med Commun 2006;27:91-98.
14. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, et al: Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-585.
15. Fagan GJ, Wayment H, Morris DL, Crosby PA: The albumin cobalt binding test: analytical performance of a new automated chemistry assay for the detection of ischemia modified albumin (IMA TM ). J Clin Ligand Assay 2002;25:178-187.
16. Appleton DW, Sarkar B: The absence of specific copper (II)-binding site in dog albumin. A comparative study of human and dog albumins. J Biol Chem 1971;246:5040-5046.
17. Laussac JP, Sarkar B: Characterization of the copper(II)- and nickel(II)-transport site of human serum albumin. Studies of copper(II) and nickel(II) binding to peptide 1-24 of human serum albumin by 13C and 1H NMR spectroscopy. Biochemistry 1984;23:2832-2838.
18. Mohanakrishnan P, Chignell CF, Cox RH: Chloride ion nuclear magnetic resonance spectroscopy probe studies of copper and nickel binding to serum albumins. J Pharm Sci 1985;74:1:61-62.